Alnylam Pharmaceuticals
ALNY
#800
Rank
$31.09 B
Marketcap
$232.40
Share price
2.47%
Change (1 day)
-51.17%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company